Tear film volume and stability

Tear film volume and stability refers to the physiological integrity and quantity of the complex fluid layer covering the ocular surface, which is essential for visual clarity and the health of the cornea and conjunctiva. The tear film is traditionally described as a tri-layered structure consisting of an inner mucin layer, a middle aqueous layer, and an outer lipid layer, though modern models suggest a more integrated muco-aqueous gel. Its primary biological functions include maintaining a smooth refractive surface, providing lubrication, and delivering antimicrobial proteins to the eye. Instability or reduced volume of the tear film is the hallmark of Dry Eye Disease (DED), a condition characterized by a loss of homeostasis of the tear film. This dysfunction can lead to hyperosmolarity and ocular surface inflammation, which further destabilizes the film in a self-perpetuating cycle. While 'tear film volume and stability' is a clinical endpoint rather than a single molecular target, numerous drugs are designed to modulate this system. These include anti-inflammatories that protect the secretory tissues and cholinergic agonists or neurostimulators that promote the secretion of natural tear components to restore normal volume and stability.

Other names

Tear film homeostasisPrecorneal tear filmTear film integrityTear stabilityTear film dynamics

Pharmacological agents improve tear film volume and stability by increasing aqueous production through neurostimulation (e.g., varenicline), reducing T-cell mediated inflammation to restore lacrimal gland and goblet cell function (e.g., cyclosporine, lifitegrast), or providing exogenous lubrication and osmoprotection (artificial tears).